MedTrace Logo

Transitioning Together Boston

NCT05599711 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2025-11-24

No results posted yet for this study

Summary

A randomized controlled trial will be conducted to determine the effects of an adapted family-centered autism transition intervention called Transitioning Together/Juntos en la Transición on meaningful outcomes for families. The study will occur in a safety net hospital setting. The adapted version of this multi-family group psychoeducation intervention is delivered across one individual family joining session and four 2.5 hour multi-family group sessions. The parent and youth groups are held in separately, at the same time.

Conditions

  • Autism or Autistic Traits
  • Family Relations

Interventions

BEHAVIORAL

Transitioning Together (TT) / Juntos en la Transicion (JET)

1. One individual family joining session when each family dyad meets with group therapists to establish rapport and share their own unique family's background, goals, and supports. 2. A series of four 2.5-hour multi-family group psychoeducation intervention sessions focused on problem-solving education and psychoeducational autism transition-to-adulthood content which can include independence in adulthood, community involvement, guardianship and legal issues, employment and education, health and well-being.

BEHAVIORAL

Usual autism transition care

An expedited referral will be made for participants to establish care with a BMC Autism Program Transition/Resource Specialist. Data will be abstracted from the electronic medical record on how many visits each family completes with a BMC Autism Program Transition/Resource Specialist or other BMC Developmental and Behavioral Pediatrics provider throughout the study period.

Sponsors & Collaborators

  • Deborah Munroe Noonan Memorial Research Fund

    collaborator OTHER

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Jocelyn L Kuhn, PhD · Emory School of Medicine

  • Mei Elansary, MD · Boston Medical Center, Pediatrics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-10
Primary Completion
2026-10-31
Completion
2026-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05599711 on ClinicalTrials.gov